Division of Psychiatry, Imperial College London, UK; and Drug Science, London, UK.
Addiction Psychiatry, Keele University, UK.
Br J Psychiatry. 2024 Aug;225(2):308-310. doi: 10.1192/bjp.2024.76.
Australia has just rescheduled two drugs controlled under the United Nations Psychotropic Drug Conventions, psilocybin and MDMA, as treatments for treatment-resistant depression and post-traumatic stress disorder respectively. This feature explores the reasons for these developments, the opportunities and challenges they provide to psychiatry communities and how along with health systems these communities might respond to these developments.
澳大利亚刚刚重新安排了两种受联合国《精神药物公约》管制的药物，即裸盖菇素和 MDMA，分别作为治疗难治性抑郁症和创伤后应激障碍的药物。本专题探讨了这些发展的原因、它们为精神病学领域提供的机会和挑战，以及这些领域及其所在的卫生系统可能如何应对这些发展。
